Spark Therapeutics Stock Forecast
The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The global market for targeted therapeutics is forecast to grow from $100.9 billion in 2021 to $142.6 billion by 2026, at a compound annual growth rate (cagr) of.
#3297 out of 3492 analysts.
Spark therapeutics stock forecast. Spark therapeutics, a unit of roche holdings ag. You'll find the spark therapeutics share forecasts, stock quote and buy / sell signals below.according to present data spark therapeutics's once shares and. This price target is based on 0 analysts offering 12 month price targets for spark therapeutics in the last 3 months.
Get instant access to a free live streaming chart of the spark therapeutics inc stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines. Shares in spark therapeutics inc are currently trading at $113.57 and the price has moved by 0.183k% over the past 365 days.
Looking forward, the market is expected to reach a value of us$ 19.13 billion by 2026, expanding at a cagr of 1. Earnings for spark therapeutics are expected to grow in the coming year, from ($5.07) to ($4.34) per share. 35% 12 out of 34.
This price represents a premium of about 122% to spark therapeutics' closing price on feb 22, 2019. Spark networks 10% owner osmium diamond lp acquired a total of 1654197 shares at an average price of $2.51. Crispr therapeutics ag stock price forecast for 2023:
Industry n/a spark therapeutics inc. Spark networks 10% owner osmium diamond lp acquired a total of 1654197 shares at an average price of $2.51. 8, 2021 at 11:15 p.m.
Spark therapeutics's earnings are expected to grow from ($5.07) per share to ($4.34) per share in the next year. The total value of the deal is $4.8 billion. #482 out of 3495 analysts.
It does it by using a virus to insert new genes into patients.wall street stock market & finance report, prediction for the future: 48% 12 out of 25. Want to get rid of this ad?
Our mission at spark therapeutics is to challenge the inevitability of genetic disease by discovering, developing and delivering potential treatments in ways unimaginable—until now. Focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. This page was last updated on 11/30/2021 by marketbeat.com staff
The global asthma therapeutics market reached a value of us$ 17.6 billion in 2020. Lov) gained 15% to $3.0699. What is spark therapeutics's eps forecast for next year?
Price to earnings ratio vs. Price to earnings ratio vs. Spark networks se (nyse:lov) gained 15% to $3.0699.
Post a Comment for "Spark Therapeutics Stock Forecast"